Notice Pursuant to the National Cooperative Research and Production Act of 1993-Pistoia Alliance, Inc., 23298 [2017-10358]
Download as PDF
<![CDATA[
23298
Federal Register / Vol. 82, No. 97 / Monday, May 22, 2017 / Notices
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Antitrust Division
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Pistoia Alliance, Inc.
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—International Electronics
Manufacturing Initiative, Inc.
Notice is hereby given that, on April
24, 2017, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Pistoia Alliance, Inc.
has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Shire Pharmaceuticals
LLC, Lexington, MA; Lhasa Limited,
Leeds, UNITED KINGDOM;
Intomics A/S, Lyngby, DENMARK; and
PRYV SA, Lausanne, SWITZERLAND,
have been added as parties to this
venture.
Also, Chris Barber (individual
member), Leeds, UNITED KINGDOM,
has withdrawn as a party to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and Pistoia
Alliance, Inc. intends to file additional
written notifications disclosing all
changes in membership.
On May 28, 2009, Pistoia Alliance,
Inc. filed its original notification
pursuant to Section 6(a) of the Act. The
Department of Justice published a notice
in the Federal Register pursuant to
Section 6(b) of the Act on July 15, 2009
(74 FR 34364).
The last notification was filed with
the Department on February 3, 2017. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on March 7, 2017 (82 FR 12847).
Notice is hereby given that, on April
26, 2017, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), International
Electronics Manufacturing Initiative,
Inc. (‘‘iNEMI’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, 5N Plus Micro Powders
´
Inc., Montreal, Quebec, CANADA; U.S.
Department of Defense, Fort Meade,
MD; Elmatica AS, Oslo, NORWAY;
Integrated Micro-Electronics, Inc.,
Binan, PHILIPPINES; General Electric,
San Jose, CA; Oak Ridge National
Laboratory, Oak Ridge, TN; Tin
Products Manufacturing Co., LTD,
Kunming, PEOPLE’S REPUBLIC OF
CHINA; Vitrox Technologies SDN BHD,
Bayan Lepas, MALAYSIA; METech
Recycling, Creedmoor, NC; Peagatroin,
Taipei, TAIWAN; Shenmao Technology,
Inc., Taoyuan, TAIWAN; SAKI
Corporation, Tokyo, JAPAN; SENKO
Advanced Components, Basingstoke,
UNITED KINGDOM; and Abbott
Corporation, Abbott Park, IL, have been
added as parties to this venture.
` ´
Also, Commissariat a l’energie
´
atomique et aux energies alternatives,
Grenoble, FRANCE; EPEAT, Inc.,
Portland, OR; Underwriters
Laboratories, Northbrook, IL; IMEC vzw,
Leuven, BELGIUM; Micro Systems
Technology Mgmt. AG, Baar,
SWITZERLAND; TE Connectivity,
Schaffhausen, SWITZERLAND; and St.
Jude Medical, Saint Paul, MN, have
withdrawn as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and iNEMI
intends to file additional written
notifications disclosing all changes in
membership.
On June 6, 1996, iNEMI filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on June 28, 1996 (61 FR 33774).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
mstockstill on DSK30JT082PROD with NOTICES
[FR Doc. 2017–10358 Filed 5–19–17; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
23:17 May 19, 2017
Jkt 241001
PO 00000
Frm 00129
Fmt 4703
Sfmt 4703
The last notification was filed with
the Department on May 4, 2016. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on June 9, 2016 (81 FR 37213).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2017–10342 Filed 5–19–17; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Steven Bernhard, D.O.; Decision and
Order
On October 3, 2016, the Assistant
Administrator, Division of Diversion
Control, Drug Enforcement
Administration, issued an Order to
Show Cause to Steven Bernhard, D.O.
(hereinafter, Registrant), of Bayside,
New York. The Show Cause Order
proposed the revocation of Registrant’s
Certificate of Registration on the
grounds that: (1) He materially falsified
his renewal application, and (2) he lacks
authority to handle controlled
substances in New York, the State in
which he is registered. GX D, at 1 (citing
21 U.S.C. 823(f), 824(a)(1), and
824(a)(3)).
As to the Agency’s jurisdiction, the
Show Cause Order alleged that
Registrant is the holder of DEA
Certificate of Registration AB7719860,
pursuant to which he is registered as a
practitioner in schedules II through V at
the registered address of 39–21 Bell
Blvd., Bayside, New York. Id. The Order
alleged that this registration does not
expire until July 31, 2018. Id.
As to the substantive grounds for the
proceeding, the Show Cause Order
alleged that effective on ‘‘February 4,
2013, the New York Department of
Health State Board for Professional
Misconduct revoked [his] license to
practice medicine due to negligence,
incompetence, gross negligence, gross
incompetence, the failure to maintain
records, fraudulent practice, and false
reports,’’ and that ‘‘[t]his order remains
in effect.’’ Id. The Show Cause Order
thus alleged that Registrant is ‘‘without
authority to handle controlled
substances in the State of New York, the
[S]tate in which [he is] registered,’’ and
that his registration is therefore subject
to revocation. Id. at 1–2 (citing 21 U.S.C.
823(f) & 824(a)(3)).
The Show Cause Order also alleged
that on June 11, 2015, Registrant
submitted a renewal application for his
registration on which he made two
materially false statements. Id. at 2.
E:\FR\FM\22MYN1.SGM
22MYN1
]]>Agencies
[Federal Register Volume 82, Number 97 (Monday, May 22, 2017)]
[Notices]
[Page 23298]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-10358]
[[Page 23298]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Pistoia Alliance, Inc.
Notice is hereby given that, on April 24, 2017, pursuant to Section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), Pistoia Alliance, Inc. has filed
written notifications simultaneously with the Attorney General and the
Federal Trade Commission disclosing changes in its membership. The
notifications were filed for the purpose of extending the Act's
provisions limiting the recovery of antitrust plaintiffs to actual
damages under specified circumstances. Specifically, Shire
Pharmaceuticals LLC, Lexington, MA; Lhasa Limited, Leeds, UNITED
KINGDOM; Intomics A/S, Lyngby, DENMARK; and PRYV SA, Lausanne,
SWITZERLAND, have been added as parties to this venture.
Also, Chris Barber (individual member), Leeds, UNITED KINGDOM, has
withdrawn as a party to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and Pistoia Alliance, Inc. intends to
file additional written notifications disclosing all changes in
membership.
On May 28, 2009, Pistoia Alliance, Inc. filed its original
notification pursuant to Section 6(a) of the Act. The Department of
Justice published a notice in the Federal Register pursuant to Section
6(b) of the Act on July 15, 2009 (74 FR 34364).
The last notification was filed with the Department on February 3,
2017. A notice was published in the Federal Register pursuant to
Section 6(b) of the Act on March 7, 2017 (82 FR 12847).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2017-10358 Filed 5-19-17; 8:45 am]
BILLING CODE P
